Latest filings (excl ownership)
S-8
Registration of securities for employees
19 Apr 24
8-K
Notable Labs Reports 2023 Financial Results and Provides a Business Update
12 Apr 24
10-K
2023 FY
Annual report
11 Apr 24
8-K
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
9 Apr 24
8-K
Other Events
8 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
25 Mar 24
8-K
Changes in Registrant's Certifying Accountant
21 Mar 24
8-K
Other Events
22 Feb 24
DEF 14A
Definitive proxy
16 Feb 24
PRE 14A
Preliminary proxy
5 Feb 24
8-K
Changes in Registrant's Certifying Accountant
2 Feb 24
RW
Registration withdrawal request
8 Jan 24
8-K
Other Events
18 Dec 23
8-K/A
Financial Statements and Exhibits
29 Nov 23
8-K/A
Financial Statements and Exhibits
29 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
14 Nov 23
8-K
Other Events
20 Oct 23
S-3
Shelf registration
17 Oct 23
8-K
Regulation FD Disclosure
17 Oct 23
8-K
Notable Labs Closes Merger Transaction With VBL Therapeutics
16 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
12 Oct 23
425
Business combination disclosure
10 Oct 23
8-K
Other Events
10 Oct 23
425
Business combination disclosure
4 Oct 23
425
Business combination disclosure
2 Oct 23
8-K
Other Events
2 Oct 23
424B3
Prospectus supplement
2 Oct 23
425
Business combination disclosure
18 Sep 23
8-K
Other Events
18 Sep 23
424B3
Prospectus supplement
18 Sep 23
425
Business combination disclosure
6 Sep 23
8-K
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
6 Sep 23
EFFECT
Notice of effectiveness
6 Sep 23
SEC STAFF LETTER
SEC staff letter
6 Sep 23
ARS
2022 FY
Annual report to shareholders
5 Sep 23
424B3
Prospectus supplement
5 Sep 23
Latest ownership filings
4
Peter Feinberg
26 Jan 24
4
Tuomo Patsi
26 Jan 24
4
Michele Galen
26 Jan 24
4
Thomas Graney
26 Jan 24
4
THOMAS I H DUBIN
26 Jan 24
4
YEHUDA MICHAEL RICE
26 Jan 24
SC 13G/A
FR Capital Holdings, L.P.
11 Jan 24
4
Change in insider ownership
3 Jan 24
4
Change in insider ownership
2 Jan 24
4
Change in insider ownership
28 Dec 23
4
Change in insider ownership
26 Dec 23
3
Initial statement of insider ownership
26 Oct 23
SC 13G
FR Capital Holdings, L.P.
26 Oct 23
3
Initial statement of insider ownership
26 Oct 23
SC 13G
B Capital Fund II, L.P.
26 Oct 23
SC 13D
Builders VC Fund I (Canada), L.P.
19 Oct 23
3
JAMES JIMIN KIM
19 Oct 23
3
THOMAS I H DUBIN
18 Oct 23
3
Thomas Bock
18 Oct 23
3
Tuomo Patsi
18 Oct 23
3
Joseph P Wagner
18 Oct 23
3
Michele Galen
18 Oct 23
3
Peter Feinberg
18 Oct 23
3
Scott Alan McPherson
18 Oct 23
3
Thomas Graney
18 Oct 23
4
Samuel Backenroth
18 Apr 23
3
MARC D KOZIN
3 Jan 23
3
Dror Harats
3 Jan 23
3
Ruth Alon
3 Jan 23
3
DAVID C HASTINGS
3 Jan 23
3
Samuel Backenroth
3 Jan 23
3
YEHUDA MICHAEL RICE
3 Jan 23
3
Zvi Shmuel Ben
3 Jan 23
SC 13G
Slager David Mark
1 Feb 22
SC 13G/A
Aurum Ventures M.K.I. Ltd.
31 Jan 22
SC 13D/A
Thai Lee Family Trust
15 Nov 21
SC 13G/A
Aurum Ventures M.K.I. Ltd.
3 Aug 20
SC 13D/A
Thai Lee Family Trust
26 May 20
SC 13G
ARMISTICE CAPITAL, LLC
18 May 20
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20